Back to
MAVERICK CAPITAL LTD
TGTX
Showing 0 of 12 quarters
Position history for
MAVERICK CAPITAL LTD's holdings in TG THERAPEUTICS INC
No. Maverick Capital exited its TGTX (TG Therapeutics) position in Q1 2023. Its Q4 2022 13F listed 4,318,700 shares worth $51.1M. Maverick Capital first reported TGTX in Q2 2020 and held it in 11 quarterly 13F filings.
Current Value
—
Current Shares
—
Total Value Change
$0
Total Shares Change
0
No position history available for this security.